{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:25:25Z","timestamp":1790533525188,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1532\/ijh97.07032","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T19:00:57Z","timestamp":1704222057000},"page":"233-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Successful Imatinib Treatment of Cardiac Involvement of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia Followed by Severe Hepatotoxicity"],"prefix":"10.1007","volume":"86","author":[{"given":"Ayako","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihoko","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johji","family":"Inazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,1]]},"reference":[{"key":"863233_CR1","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa025217","volume":"348","author":"J Cools","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348:1201\u20131214.","journal-title":"N Engl J Med."},{"key":"863233_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/blood-2003-08-2798","volume":"103","author":"AD Klion","year":"2004","unstructured":"Klion AD, Robyn J, Akin C, et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood. 2004;103:473\u2013478.","journal-title":"Blood"},{"key":"863233_CR3","first-page":"75","volume":"39","author":"WS Ayoub","year":"2005","unstructured":"Ayoub WS, Geller SA, Tran T, Martin P, Vierling JM, Poordad FF. Imatinib (Gleevec)-induced hepatotoxicity. j Clin Gastroenterol. 2005;39:75\u201377.","journal-title":"j Clin Gastroenterol."},{"key":"863233_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ajh.20486","volume":"81","author":"TJ Cross","year":"2006","unstructured":"Cross TJ, Bagot C, Portmann B, Wendon J, Gillett D. Imatinib mesylate as a cause of acute liver failure. Am J Hematol. 2006;81:189\u2013192.","journal-title":"Am J Hematol."},{"issue":"suppl 6","key":"863233_CR5","first-page":"ECR27","volume":"91","author":"D Ferrero","year":"2006","unstructured":"Ferrero D, Pogliani EM, Rege-Cambrin G, et al. Corticosteroids can reverse severe imatinib-induced hepatotoxicity. Haematologica. 2006;91(suppl 6):ECR27.","journal-title":"Haematologica."},{"key":"863233_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1532\/IJH97.05034","volume":"82","author":"K Ikuta","year":"2005","unstructured":"Ikuta K, Torimoto Y, Jimbo J, et al. Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management. Int J Hematol. 2005;82:343\u2013346.","journal-title":"Int J Hematol."},{"key":"863233_CR7","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/sj.leu.2402910","volume":"17","author":"C James","year":"2003","unstructured":"James C, Trouette H, Marit G, Cony-Makhoul P, Mahon FX. Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia. 2003;17:978\u2013979.","journal-title":"Leukemia"},{"key":"863233_CR8","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/sj.leu.2402702","volume":"16","author":"K Ohyashiki","year":"2002","unstructured":"Ohyashiki K, Kuriyama Y, Nakajima A, et al. Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis. Leukemia. 2002;16:2160\u20132161.","journal-title":"Leukemia"},{"key":"863233_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1365-2141.2005.05863.x","volume":"132","author":"J Robyn","year":"2006","unstructured":"Robyn J, Lemery S, Philip McCoy J, et al. Multilineage involvement of the fusion gene in patients with FIP1 L1\/PDGFRA-positive hypereosinophilic syndrome. Br J Haematol. 2006;132:286\u2013292.","journal-title":"Br J Haematol."},{"key":"863233_CR10","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1073\/pnas.0932698100","volume":"100","author":"JH Griffin","year":"2003","unstructured":"Griffin JH, Leung J, Bruner RJ, Caligiuri MA, Briesewitz R. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci USA. 2003;100:7830\u20137835.","journal-title":"Proc Natl Acad Sci USA"},{"key":"863233_CR11","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","volume":"101","author":"AD Klion","year":"2003","unstructured":"Klion AD, Noel P, Akin C, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood. 2003;101:4660\u20134666.","journal-title":"Blood"},{"key":"863233_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/sj.leu.2403229","volume":"18","author":"C Rose","year":"2004","unstructured":"Rose C, Dupire S, Roche-Lestienne C, et al. Sustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome in relapse after allograft. Leukemia. 2004;18:354\u2013355.","journal-title":"Leukemia"},{"key":"863233_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/sj.leu.2403313","volume":"18","author":"P Vandenberghe","year":"2004","unstructured":"Vandenberghe P, Wlodarska I, Michaux L, et al. Clinical and molecular features of FIP1L1-PDGFRA (+) chronic eosinophilic leukemias. Leukemia. 2004;18:734\u2013742.","journal-title":"Leukemia"},{"key":"863233_CR14","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","volume":"83","author":"PF Weller","year":"1994","unstructured":"Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994;83:2759\u20132779.","journal-title":"Blood"},{"key":"863233_CR15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.leukres.2005.11.014","volume":"30","author":"S Florian","year":"2006","unstructured":"Florian S, Esterbauer H, Binder T, et al. Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1\/PDGFR\u03b1, classification by WHO criteria, and response to therapy with imatinib. Leuk Res. 2006;30:1201\u20131205.","journal-title":"Leuk Res."},{"key":"863233_CR16","first-page":"596","volume":"90","author":"Starza R La","year":"2005","unstructured":"La Starza R, Specchia G, Cuneo A, et al. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1\/PDGFRA but not genomic rearrangements of other tyrosine kinases. Haematologica. 2005;90:596\u2013601.","journal-title":"Haematologica."},{"key":"863233_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-0609.2005.00490.x","volume":"75","author":"J Musial","year":"2005","unstructured":"Musial J, Brzezinska-Kolarz B, Sanak M, Szczeklik A. Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinib. Eur J Haematol. 2005;75:87\u201388.","journal-title":"Eur J Haematol."},{"key":"863233_CR18","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1080\/10428190400002293","volume":"45","author":"B Rotoli","year":"2004","unstructured":"Rotoli B, Catalano L, Galderisi M, et al. Rapid reversion of Loeffler\u2019s endocarditis by imatinib in early stage clonal hypereosinophilic syndrome. Leuk Lymphoma. 2004;45:2503\u20132507.","journal-title":"Leuk Lymphoma."},{"key":"863233_CR19","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1182\/blood-2003-07-2323","volume":"102","author":"NU Lin","year":"2003","unstructured":"Lin NU, Sarantopoulos S, Stone JR, et al. Fatal hepatic necrosis following imatinib mesylate therapy. Blood. 2003;102:3455\u20133456.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1532\/IJH97.07032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1532\/IJH97.07032\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1532\/IJH97.07032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T19:31:22Z","timestamp":1704223882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1532\/IJH97.07032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":19,"aliases":["10.1007\/bf03006926"],"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["863233"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.07032","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"22 February 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}